FibroGen Inc (NASDAQ:FGEN)
| 0.652 Delayed Data As of 3:59pm ET |  +0.0236 / +3.76%Today’s Change | 0.33 Today|||52-Week Range 25.69 | -95.93% Year-to-Date |
Latest FGEN News | Press Releases
No recent news for FibroGen Inc.
Today’s Trading
| Previous close | 0.63 |
| Today’s open | 0.63 |
| Day’s range | 0.62 - 0.68 |
| Volume | 75,406 |
| Average volume (3 months) | 3,715,524 |
| Market cap | $62.0M |
Data as of 3:59pm ET, 12/04/2023
Growth & Valuation
| Earnings growth (last year) | +0.08% |
| Earnings growth (this year) | +14.60% |
| Earnings growth (next 5 years) | +28.42% |
| Revenue growth (last year) | -40.19% |
| P/E ratio | NM |
| Price/Sales | 10.65 |
| Price/Book | -- |
Financials
| Next reporting date | February 26, 2024 |
| EPS forecast (this quarter) | -$0.54 |
| Annual revenue (last year) | $140.7M |
| Annual profit (last year) | -$293.7M |
| Net profit margin | -208.66% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Francisco, California |
Forecasts
